SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015)
SELLAS Life Sciences (SLS) posted quarterly Amortization - Intangibles of $442000.0 for Q2 2015, up 351.02% year-over-year from $98000.0 in Q2 2014, and up 202.74% quarter-over-quarter from $146000.0 in Q1 2015.
Analysis
SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Amortization - Intangibles for 3 consecutive years, with $442000.0 the latest figure, recorded in Q2 2015.
- In Q2 2015, Amortization - Intangibles rose 351.02% year-over-year to $442000.0; the TTM figure through Jun 2015 stood at $756000.0 (up 225.86% YoY), while the FY2017 annual figure was $1.9 million, changed N/A from the prior year.
- Amortization - Intangibles rose to $442000.0 in Q2 2015 per SLS's latest filing, from $146000.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $442000.0 in Q2 2015 and bottomed at $43000.0 in Q3 2013.
- Historically, Amortization - Intangibles has averaged $148333.3 across 3 years, with a median of $94500.0 in 2014.
- On a YoY basis, Amortization - Intangibles climbed as much as 351.02% in 2015 and fell as far as 60.44% in 2015.
- SELLAS Life Sciences' Amortization - Intangibles stood at $43000.0 in 2013, then jumped by 62.79% to $70000.0 in 2014, then soared by 531.43% to $442000.0 in 2015.
- Business Quant data shows SLS's Amortization - Intangibles at $442000.0 in Q2 2015, $146000.0 in Q1 2015, and $70000.0 in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | SELLAS Life Sciences | 2.62 Bn | 2.62 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 442,000.00 |
| Mar 31, 2015 | 146,000.00 |
| Sep 30, 2014 | 70,000.00 |
| Jun 30, 2014 | 98,000.00 |
| Mar 31, 2014 | 91,000.00 |
| Sep 30, 2013 | 43,000.00 |